| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Molecular Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20205 [S. S. P., T. F., D. W., H. V. G.], and Department of Biochemistry and Center in Environmental Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 [F. P. G.]
Somatic cell hybrids were made between mouse myeloma cells and spleen cells derived from BALB/c mice immunized with liver microsomal cytochrome P-450 purified from rats treated with 3-methylcholanthrene (MC-P-450). Thirty-seven independent hybrid clones among 66 tested produced monoclonal antibodies to the MC-P-450 as measured by radioimmunoassay. More than 10 of the monoclonal antibodies formed were positive for MC-P-450 with respect to protein binding measured by radioimmunoassay, precipitation of the enzyme caused by antibody binding and enzyme aggregation, and inhibition of enzymatic activity. Analysis by gel electrophoresis indicated that a single microsomal protein band interacted with the antibody and that this band comigrated with MC-P-450. These monoclonal antibodies interacted with the major form of cytochrome P-450 from ß-naphthoflavone-induced rats as well as with MC-P-450 but did not bind, precipitate, or inhibit the activity of the major form of cytochrome P-450 from phenobarbital-treated rats. The monoclonal antibodies inhibited 7-ethoxycoumarin deethylase and benzo(a)pyrene hydroxylation activity of the purified MC-P-450 with varying degrees, up to 90%, the latter as measured by the aryl hydrocarbon hydroxylase assay for phenol production. Analysis of benzo(a)pyrene metabolism by high-pressure liquid chromatography indicated that the monoclonal antibodies inhibited the enzyme activity of the purified MC-P-450 at all of the positions at which oxidation occurs. The monoclonal antibodies also inhibited both aryl hydrocarbon hydroxylase and 7-ethoxycoumarin deethylase of liver microsomes from 3-methylcholanthrene-treated rats by 70%, indicating that these activities are functions affected by antibody binding to a common or identical antigenic site on cytochrome(s) P-450 which account for 70% of the total activity in these microsomes. Microsomes from control or phenobarbital-treated rats were unaffected, suggesting that their enzyme activity is a function of a cytochrome P-450 other than that sensitive to the MC-P-450 directed antibody and that the latter P-450 is absent in these microsomes. High-pressure liquid chromatographic analysis of antibody inhibition of benzo-(a)pyrene metabolism by microsomes from 3-methylcholanthrene-treated rats showed an inhibition of phenol and diol formation that ranged from 46 to 72%. 1,6-Quinone production was not affected, which suggests that this metabolite was formed by another cytochrome P-450 isozyme or nonenzymatically. The purity, specificity, and potential immortality of their hybridoma cell source will make the monoclonal antibodies extraordinarily useful for the study of substrate and inducer specificity and in the identification and quantitative assay of multiple forms of the cytochrome P-450 and the determination of their content and function in different tissues, species, and individuals.
1 Recipient of Research Career Development Award ES00041 from the USPHS.
2 To whom requests for reprints should be addressed.
Received 9/10/81. Accepted 1/25/82.
This article has been cited by other articles:
|
|
 |
|
  X. Ma, J. R. Idle, M. A. Malfatti, K. W. Krausz, D. W. Nebert, C.-S. Chen, J. S. Felton, D. J. Waxman, and F. J. Gonzalez Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Carcinogenesis, March 1, 2007; 28(3): 732 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. V. Gelboin and K. Krausz Monoclonal antibodies and multifunctional cytochrome p450: drug metabolism as paradigm. J. Clin. Pharmacol., March 1, 2006; 46(3): 353 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cheung, A.-M. Yu, J. M. Ward, K. W. Krausz, T. E. Akiyama, L. Feigenbaum, and F. J. Gonzalez THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY Drug Metab. Dispos., March 1, 2005; 33(3): 449 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Meyer, M. Podvinec, and U. A. Meyer Cytochrome P450 CYP1A1 Accumulates in the Cytosol of Kidney and Brain and Is Activated by Heme Mol. Pharmacol., November 1, 2002; 62(5): 1061 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Yang, K. W. Krausz, Y. Sai, F. J. Gonzalez, and H. V. Gelboin Eight Inhibitory Monoclonal Antibodies Define the Role of Individual P-450s in Human Liver Microsomal Diazepam, 7-Ethoxycoumarin, and Imipramine Metabolism Drug Metab. Dispos., January 1, 1999; 27(1): 102 - 109. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Levine, E. Y. W. Law, S. M. Bandiera, T. K. H. Chang, and G. D. Bellward In Vivo Cimetidine Inhibits Hepatic CYP2C6 and CYP2C11 but Not CYP1A1 in Adult Male Rats, J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 493 - 499. [Abstract] [Full Text]
|
|
|
|
|
|
L. Zhou, R. R. Erickson, J. P. Hardwick, S. S. Park, S. A. Wrighton, and J. L. Holtzman Catalysis of the Cysteine Conjugation and Protein Binding of Acetaminophen by Microsomes from a Human Lymphoblast Line Transfected with the cDNAs of Various Forms of Human Cytochrome P450 J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 785 - 790. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Song, H. Gelboin, S. Park, G. Tsokos, and F. Friedman Monoclonal antibody-directed radioimmunoassay detects cytochrome P-450 in human placenta and lymphocytes Science, April 26, 1985; 228(4698): 490 - 492. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
